Free tool
FAERS Monitor: Gocovri
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208944 or its brand name (Gocovri, Amantadine Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
15,734
Serious
9,513
60% of reports
Hospitalization
4,812
Death reported
1,674
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fall1,821
- hallucination1,356
- drug ineffective1,295
- fatigue1,118
- dyskinesia1,114
- dizziness962
- gait disturbance922
- death898
- tremor819
- nausea694
- parkinson^s disease678
- asthenia663
- condition aggravated658
- confusional state650
- balance disorder639
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 15 |
| 2005 | 113 |
| 2006 | 3 |
| 2007 | 6 |
| 2008 | 24 |
| 2009 | 41 |
| 2010 | 95 |
| 2011 | 37 |
| 2012 | 148 |
| 2013 | 406 |
| 2014 | 475 |
| 2015 | 643 |
| 2016 | 888 |
| 2017 | 1,095 |
| 2018 | 1,455 |
| 2019 | 1,436 |
| 2020 | 1,599 |
| 2021 | 1,593 |
| 2022 | 1,471 |
| 2023 | 959 |
| 2024 | 1,055 |
| 2025 | 1,223 |
| 2026 | 952 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,425 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| dyskinesiaSignal | 1,114 | 37.6 | 35.5 | 38,690 |
| hallucinationSignal | 1,356 | 24.5 | 23.2 | 30,066 |
| balance disorderSignal | 639 | 9.9 | 9.2 | 5,117 |
| fallSignal | 1,821 | 7.3 | 7.0 | 10,087 |
| tremorSignal | 819 | 6.6 | 6.2 | 3,917 |
| gait disturbanceSignal | 922 | 6.5 | 6.1 | 4,273 |
| confusional stateSignal | 650 | 5.4 | 5.0 | 2,331 |
| condition aggravatedSignal | 658 | 2.9 | 2.7 | 826 |
| dizzinessSignal | 962 | 2.6 | 2.4 | 951 |
| astheniaSignal | 663 | 2.4 | 2.2 | 526 |
| fatigue | 1,118 | 1.9 | 1.8 | 511 |
| death | 898 | 1.4 | 1.3 | 104 |
| drug ineffective | 1,295 | 1.3 | 1.2 | 103 |
| nausea | 694 | 1.2 | 1.1 | 18 |
| parkinson^s disease | 678 | 0.0 | 0.0 | 905,267 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.